Single-cell ploidy analysis reveals polyploidy effects on tumor aggressiveness and immune suppression in intrahepatic cholangiocarcinoma
Intrahepatic cholangiocarcinoma (iCCA) is a primary liver cancer with poor prognosis. Pan-cancer genomic analyses have suggested that polyploidization contributes to cancer progression, by promoting chromosomal instability and malignant evolution. However, its impact on iCCA remains unexplored, partly due to the abundance of stroma and the limited cohort size. This study assessed tumor cell ploidy at the single-cell level via chromosome FISH to examine its association with intratumoral heterogeneity and effects on iCCA pathogenesis. Both iCCA and hepatocellular carcinoma exhibited intratumoral heterogeneity in tumor cell ploidy, with a strong correlation between median ploidy and heterogeneity levels. Polyploid iCCA demonstrated aggressive features including high invasiveness, increased proliferation, and poor differentiation. Tumor cells in polyploid iCCA overexpressed IL6, potentially driving tumor aggressiveness, while suppressing anti-tumor immunity. These findings highlight ploidy alterations as determinants of iCCA pathogenesis and suggest that targeting ploidy could offer a novel approach to precision medicine for iCCA.
Authors
- Miki Kawano
- Tomonori Matsumoto (ORCID: https://orcid.org/0000-0003-4483-2178)
- Kenji Nagata (ORCID: https://orcid.org/0000-0002-9955-9431)
- Taku Kitano
- Yoshiyuki Harada
- Eiji Hara (ORCID: https://orcid.org/0000-0001-7821-3960)
- Masahiro Kido
- Takumi Fukumoto
- Takanori Matsuura
- Yoshihide Ueda
- Yuzo Kodama
- Shohei Komatsu
Institutions
- Kyoto University (JP)
- Kagawa Prefectural Central Hospital (JP)
- Kobe University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- npj Precision Oncology
- Published
- 2026-08-03
- DOI
- https://doi.org/10.1038/s41698-026-01637-1
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development
- Astellas Foundation for Research on Metabolic Disorders
- Princess Takamatsu Cancer Research Fund
- Japan Society for the Promotion of Science
- Japan Science and Technology Agency